Neuropeptidomic Components Generated by Proteomic Functions in Secretory Vesicles for Cell–Cell Communication

Diverse neuropeptides participate in cell–cell communication to coordinate neuronal and endocrine regulation of physiological processes in health and disease. Neuropeptides are short peptides ranging in length from ~3 to 40 amino acid residues that are involved in biological functions of pain, stress, obesity, hypertension, mental disorders, cancer, and numerous health conditions. The unique neuropeptide sequences define their specific biological actions. Significantly, this review article discusses how the neuropeptide field is at the crest of expanding knowledge gained from mass-spectrometry-based neuropeptidomic studies, combined with proteomic analyses for understanding the biosynthesis of neuropeptidomes. The ongoing expansion in neuropeptide diversity lies in the unbiased and global mass-spectrometry-based approaches for identification and quantitation of peptides. Current mass spectrometry technology allows definition of neuropeptide amino acid sequence structures, profiling of multiple neuropeptides in normal and disease conditions, and quantitative peptide measures in biomarker applications to monitor therapeutic drug efficacies. Complementary proteomic studies of neuropeptide secretory vesicles provide valuable insight into the protein processes utilized for neuropeptide production, storage, and secretion. Furthermore, ongoing research in developing new computational tools will facilitate advancements in mass-spectrometry-based identification of small peptides. Knowledge of the entire repertoire of neuropeptides that regulate physiological systems will provide novel insight into regulatory mechanisms in health, disease, and therapeutics.

[1]  R. Holz,et al.  Synaptic Transmission and Cellular Signaling: An Overview , 2012 .

[2]  D. O'Connor,et al.  Proteomics of dense core secretory vesicles reveal distinct protein categories for secretion of neuroeffectors for cell-cell communication. , 2010, Journal of proteome research.

[3]  Nitin Gupta,et al.  Mass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processing. , 2010, Journal of proteome research.

[4]  C. Peters,et al.  Cathepsin L participates in dynorphin production in brain cortex, illustrated by protease gene knockout and expression , 2010, Molecular and Cellular Neuroscience.

[5]  J. Burbach,et al.  Neuropeptides from concept to online database www.neuropeptides.nl. , 2010, European journal of pharmacology.

[6]  Proceedings of Invertebrate Neuropeptide Conference 2009 (INC2009). January 11-15, 2009. Khajuraho, India. , 2010, Peptides.

[7]  Geert Wets,et al.  Bioinformatic approaches to the identification of novel neuropeptide precursors. , 2010, Methods in molecular biology.

[8]  R. Blantz,et al.  Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry. , 2009, Analytical biochemistry.

[9]  Jean-Charles Sanchez,et al.  Proteomics of regulated secretory organelles. , 2009, Mass spectrometry reviews.

[10]  V. Hook,et al.  Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS. , 2009, Biochemistry.

[11]  S. Bark,et al.  Linear and accurate quantitation of proenkephalin-derived peptides by isotopic labeling with internal standards and mass spectrometry. , 2009, Analytical biochemistry.

[12]  V. Hook,et al.  Proteolytic Fragments of Chromogranins A and B Represent Major Components of Chromaffin Granules, Illustrated by 2-D Proteomics with NH2-Terminal Edman Peptide Sequencing and MALDI-TOF MS , 2009 .

[13]  S. Rodriguez-Zas,et al.  Characterization of the prohormone complement in cattle using genomic libraries and cleavage prediction approaches , 2009, BMC Genomics.

[14]  Samuel H. Payne,et al.  Discovery and revision of Arabidopsis genes by proteogenomics , 2008, Proceedings of the National Academy of Sciences.

[15]  C. Peters,et al.  Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, β-Endorphin, and α-MSH, Illustrated by Protease Gene Knockout and Expression* , 2008, Journal of Biological Chemistry.

[16]  Vivian Hook,et al.  Differential activation of enkephalin, galanin, somatostatin, NPY, and VIP neuropeptide production by stimulators of protein kinases A and C in neuroendocrine chromaffin cells , 2008, Neuropeptides.

[17]  Jeffrey M Perkel,et al.  Neuropeptidomics study profiles hypothalamic "nucleus", individual cells. , 2008, Journal of proteome research.

[18]  Martha U. Gillette,et al.  Neuropeptidomics of the Supraoptic Rat Nucleus , 2008, Journal of proteome research.

[19]  D. Goldstein,et al.  Adrenomedullary, adrenocortical, and sympathoneural responses to stressors: a meta-analysis. , 2008, Endocrine regulations.

[20]  C. Peters,et al.  Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression , 2008, Journal of neurochemistry.

[21]  Daniel B. Goodman,et al.  Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomes. , 2008, Genome research.

[22]  Jill L. Wegrzyn,et al.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. , 2008, Annual review of pharmacology and toxicology.

[23]  B. Cravatt,et al.  Activity-based protein profiling for the functional annotation of enzymes , 2007, Nature Methods.

[24]  L. Fricker,et al.  Neuropeptidomics to study peptide processing in animal models of obesity. , 2007, Endocrinology.

[25]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[26]  Debby Van Dam,et al.  Handbook of Biologically Active Peptides, 1st ed., A.J. Kastin (Ed.). Academic Press (2006), 1640 pp., Hardback, Price: £ 135.00, $ 229.95, € 195, ISBN: 0-12-369442-6 , 2007 .

[27]  M. Kemal Sönmez,et al.  Evolutionary Sequence Modeling for Discovery of Peptide Hormones , 2007, 2007 IEEE International Conference on Acoustics, Speech and Signal Processing - ICASSP '07.

[28]  William Arbuthnot Sir Lane,et al.  Proteomics of neuroendocrine secretory vesicles reveal distinct functional systems for biosynthesis and exocytosis of peptide hormones and neurotransmitters. , 2007, Journal of proteome research.

[29]  Robert E. Kearney,et al.  Quantitative Proteomics Analysis of the Secretory Pathway , 2006, Cell.

[30]  Michael K. Coleman,et al.  Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors. , 2006, Methods.

[31]  B. Cravatt,et al.  Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.

[32]  Jonathan V Sweedler,et al.  Bridging neuropeptidomics and genomics with bioinformatics: Prediction of mammalian neuropeptide prohormone processing. , 2006, Journal of proteome research.

[33]  M. Bogyo,et al.  A selective activity-based probe for the papain family cysteine protease dipeptidyl peptidase I/cathepsin C. , 2006, Journal of the American Chemical Society.

[34]  J. Strahler,et al.  Organellar Proteomics , 2006, Molecular & Cellular Proteomics.

[35]  Matthew Bogyo,et al.  Activity-based probes that target diverse cysteine protease families , 2005, Nature chemical biology.

[36]  D. O'Connor,et al.  Role of H+-ATPase-mediated Acidification in Sorting and Release of the Regulated Secretory Protein Chromogranin A , 2005, Journal of Biological Chemistry.

[37]  S. Pfeffer,et al.  Targeting Rab GTPases to distinct membrane compartments , 2004, Nature Reviews Molecular Cell Biology.

[38]  J. Colicelli,et al.  Human RAS Superfamily Proteins and Related GTPases , 2004, Science's STKE.

[39]  M. Bogyo,et al.  Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones , 2004, Biological chemistry.

[40]  M. Otsuka,et al.  Pain and neurotransmitters , 1990, Cellular and Molecular Neurobiology.

[41]  F. Hughson,et al.  SNARE protein structure and function. , 2003, Annual review of cell and developmental biology.

[42]  M. Bogyo,et al.  Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  O. Kosti,et al.  Adrenal neuropeptides: Regulation and interaction with ACTH and other adrenal regulators , 2003, Microscopy research and technique.

[44]  Gregory A.Petsko and Dagmar Ringe Protein structure and function , 2003 .

[45]  J. Rouleau,et al.  Vasopeptidase inhibitors: a new class of dual zinc metallopeptidase inhibitors for cardiorenal therapeutics. , 2002, Current opinion in pharmacology.

[46]  N. Seidah,et al.  Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides 1 Published on the World Wide Web on 17 August 1999. 1 , 1999, Brain Research.

[47]  B. Nankova,et al.  Multiple signalling pathways exist in the stress-triggered regulation of gene expression for catecholamine biosynthetic enzymes and several neuropeptides in the rat adrenal medulla. , 1999, Acta physiologica Scandinavica.

[48]  An Zhou,et al.  Proteolytic Processing in the Secretory Pathway* , 1999, The Journal of Biological Chemistry.

[49]  S. Yasothornsrikul,et al.  Evidence for the proenkephalin processing enzyme prohormone thiol protease (PTP) as a multicatalytic cysteine protease complex: activation by glutathione localized to secretory vesicles. , 1999, Biochemistry.

[50]  H. Loh,et al.  Regulation of opioid receptor activities. , 1999, The Journal of pharmacology and experimental therapeutics.

[51]  J. Benz,et al.  Annexins: from structure to function. , 1997, Biological chemistry.

[52]  R. Ardaillou Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. , 1997, Current opinion in nephrology and hypertension.

[53]  M. Schiller,et al.  "Prohormone thiol protease" (PTP) processing of recombinant proenkephalin. , 1995, Biochemistry.

[54]  B. Robinson,et al.  Preprocorticotropin releasing hormone: cDNA sequence and in vitro processing , 1989, Molecular and Cellular Endocrinology.

[55]  S. Sabol,et al.  Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. , 1988, The Journal of biological chemistry.

[56]  M. Brownstein,et al.  Construction of a porcine adrenal medullary cDNA library and nucleotide sequence analysis of two clones encoding a galanin precursor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Yoshikawa,et al.  Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. , 1984, The Journal of biological chemistry.

[58]  P. Seeburg,et al.  Primary structure of the human proenkephalin gene. , 1983, DNA.

[59]  David O. Norris,et al.  Vertebrate endocrinology , 1983, Nature.

[60]  L. Iversen,et al.  Brain peptides. , 1981, Science.

[61]  T. Yaksh,et al.  Pharmacology of Pain and Analgesia , 1980, Anaesthesia and intensive care.

[62]  P. Seeburg,et al.  Corticotropin and beta-endorphin: construction and analysis of recombinant DNA complementary to mRNA for the common precursor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[63]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.